A detailed history of Huntleigh Advisors, Inc. transactions in Inspire Md, Inc. stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 124,228 shares of NSPR stock, worth $305,600. This represents 0.05% of its overall portfolio holdings.

Number of Shares
124,228
Previous 117,407 5.81%
Holding current value
$305,600
Previous $316 Million 10.71%
% of portfolio
0.05%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 29, 2025

BUY
$2.19 - $2.7 $14,937 - $18,416
6,821 Added 5.81%
124,228 $282 Million
Q1 2025

Apr 29, 2025

BUY
$2.43 - $3.7 $285,299 - $434,405
117,407 New
117,407 $316 Million

Others Institutions Holding NSPR

About InspireMD, Inc.


  • Ticker NSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,323,200
  • Market Cap $20.5M
  • Description
  • InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...
More about NSPR
Track This Portfolio

Track Huntleigh Advisors, Inc. Portfolio

Follow Huntleigh Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntleigh Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Huntleigh Advisors, Inc. with notifications on news.